CNAT - Conatus Pharmaceuticals reports Q4 results
- Conatus Pharmaceuticals (NASDAQ:CNAT): Q4 GAAP EPS of -$0.08.
- More news on: Conatus Pharmaceuticals Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Link your Twitter Account to Market Wire News
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Stock Information
| Company Name: | Conatus Pharmaceuticals |
| Stock Symbol: | CNAT |
| Market: | NASDAQ |
Get CNAT Alerts
News, Short Squeeze, Breakout and More Instantly...